Compare Davita Inc (DVA) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.89. The key difference: Davita Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| DVA | MSTU | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $76.30 |
52-Week Low | $103.87 | $1.46 |
Enterprise Value | $24.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
MSTU, a leveraged ETF tracking MicroStrategy, trades at $1.995, up 6.4% in 24 hours. Technical indicators show a bullish overall signal but bearish moving averages, with key support and resistance at $2. The stock underwent a 10:1 reverse split on August 24, 2026. Financial ratios are unavailable, and recent news highlights extreme volatility and significant past losses.
Outlook remains highly speculative due to leveraged structure and dependence on MicroStrategy's Bitcoin-heavy strategy. Risks include amplified daily moves and compounding decay. Investor sentiment is cautious amid media reports of steep declines, with no clear fundamental anchor beyond underlying asset performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
